Skip to main content

Closed

ONCO: Onconetix, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-67.7% / yr

Operating margin-922.7%

ROIC-56.4%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage-12.8×

Current ratio1.41×

Onconetix, Inc.

ONCONASDAQ Capital Market·USD·Closed

Onconetix, Inc.

ONCONASDAQ·USD·Closed

$0.83

+5.12%

$0.83

+$0.04 (5.12%)

52W Range

0thpctl

Volume

0.13×avg

Mkt Cap

276142USD

P/E

-0.1TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.13×avg

Market Cap

276142USD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings